Infinity Pharmaceuticals | INFI - Ebit


Infinity Pharmaceuticals reported $-10.12M in EBIT for its fiscal quarter ending in June of 2023.





Ebit Change Date
AbbVie USD 5.81B 4.36B Dec/2025
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 3.96B 464M Dec/2025
AstraZeneca USD 2.97B 4.48B Dec/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD 56.04M 63.94M Dec/2025
CSL USD 2.64B 116M Dec/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Incyte USD 383.88M 47.44M Dec/2025
Infinity Pharmaceuticals USD -10.12M 1.39M Jun/2023
Ionis Pharmaceuticals USD -215M 54.82M Dec/2025
J&J USD 5.11B 2.3B Dec/2025
Novartis USD 4.06B 530M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Plus Therapeutics USD -5.74M 1.26M Dec/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025